SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia

We present our approach to newly diagnosed patients with B-ALL and illustrate how the incorporation of novel agents and use of high-sensitivity MRD assays can abrogate the need for allo-SCT in most patients with B-ALL.PMID:38538495 | DOI:10.1016/j.clml.2024.02.017
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research